This is the authors' abstract. We don't add key points for this paper.
channel, TREK-1, has recently emerged as an attractive therapeutic target for the development of a novel class of analgesic drugs, suggesting that activation of TREK-1 could result in pain inhibition. Here, we report the synthesis of a series of substituted acrylic acids (1-54) based on our previous work with caffeate esters. The analogues were evaluated for their ability to modulate TREK-1 channel by electrophysiology and for their in vivo antinociceptive activity (acetic acid-induced writhing and hot plate assays), leading to the identification of a series of novel molecules able to activate TREK-1 and displaying potent antinociceptive activity in vivo. Furyl analogue 36 is the most promising of the series.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vivier et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: